Editas Medicine
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.About EDIT
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).
EDIT Key Statistics
Stock Snapshot
Editas Medicine(EDIT) stock is priced at $2.97, giving the company a market capitalization of 449.22M. It carries a P/E multiple of -3.95.
During the trading session on 2026-08-21, Editas Medicine(EDIT) shares reached a daily high of $2.97 and a low of $2.96. At a current price of $2.97, the stock is +0.3% higher than the low and still 0.0% under the high.
Trading volume for Editas Medicine(EDIT) stock has reached 8.69K, versus its average volume of 2.77M.
The stock's 52-week range extends from a low of $1.66 to a high of $4.54.
The stock's 52-week range extends from a low of $1.66 to a high of $4.54.
EDIT News
Ladenburg initiated coverage of Editas Medicine (EDIT) with a Buy rating and $6 price target Published first on TheFly – the ultimate source for real-time, mar...
Analyst ratings
58%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.